Literature DB >> 10534821

Patient cost-benefit analysis of teledermatology measured in a randomized control trial.

M A Loane1, S E Bloomer, R Corbett, D J Eedy, H E Gore, N Hicks, C Mathews, J Paisley, K Steele, R Wootton.   

Abstract

A randomized controlled trial of the costs and benefits of teledermatology consultations compared with traditional hospital consultations was carried out. Over a nine-month period, 197 patients were referred from general practice for a dermatological opinion, 98 for a teledermatology consultation and 99 for a hospital consultation. Eighty patients required an additional subsequent hospital appointment. Patients were asked to complete an economic questionnaire after each consultation, and 164 questionnaires were returned: 62% of those randomized to the teledermatology consultation responded compared with 58% of those randomized to the hospital consultation. Patients seen by teledermatology at their own health centre had shorter distances to travel and spent less time overall attending the appointment compared with those seen at the hospital. However, the teledermatology consultations were more time-consuming for the general practitioner and dermatologist. These findings indicate that teledermatology has more benefits for the patient than for the health-care delivery team.

Entities:  

Mesh:

Year:  1999        PMID: 10534821     DOI: 10.1258/1357633991932414

Source DB:  PubMed          Journal:  J Telemed Telecare        ISSN: 1357-633X            Impact factor:   6.184


  2 in total

1.  Multicentre randomised control trial comparing real time teledermatology with conventional outpatient dermatological care: societal cost-benefit analysis.

Authors:  R Wootton; S E Bloomer; R Corbett; D J Eedy; N Hicks; H E Lotery; C Mathews; J Paisley; K Steele; M A Loane
Journal:  BMJ       Date:  2000-05-06

Review 2.  Interactive telemedicine: effects on professional practice and health care outcomes.

Authors:  Gerd Flodgren; Antoine Rachas; Andrew J Farmer; Marco Inzitari; Sasha Shepperd
Journal:  Cochrane Database Syst Rev       Date:  2015-09-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.